Name: Recombinant Technology in Hemostasis and Thrombosis (en Inglés)
Price: 1201.34 MXN
Availability: InStock
Author: Drohan, W. N. ; Hoyer, Leon W.
ISBN: 9781461366447

Envío gratis

portada Recombinant Technology in Hemostasis and Thrombosis (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Drohan, W. N. ; Hoyer, Leon W.

Idioma

Inglés

N° páginas

261

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 1.4 cm

Peso

0.48 kg.

ISBN13

9781461366447

Categorías

Hematología
Bioquímica
Botánica y ciencias de las plantas

Recombinant Technology in Hemostasis and Thrombosis (en Inglés)

Drohan, W. N. ; Hoyer, Leon W. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 1,201.34

$ 2,184.25

Ahorras: $ 982.91

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 22 de Julio y el Viernes 02 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Recombinant Technology in Hemostasis and Thrombosis (en Inglés)"

Recent progress in molecular biology has led to a rapid expansion of our understanding of the proteins that are essential for hemostasis and thrombosis. The goal of the XXI Annual Scientific Symposium of the American Red Cross was to provide a forum to explore and document the impact of recombinant DNA technology in this field. The speakers described the essential features of the genes responsible for key plasma proteins important in hemostasis, including procoagulant Factors VIII and IX and anticoagulant proteins, Antithrombin III and Protein C. They emphasized the advances in recombinant DNA technology that have led to the cloning of these genes. Careful examination of the gene sequence has then provided a clearer understanding of the structure of the encoded proteins, and has given additional insight into their functional domains and their interactions in hemostasis. At the same time, these advances have made it possible to better characterize hemostatic disorders. A large number of published studies have shown that the mutations affecting biological activity are clustered in areas that define functional domains. They have led to fundamental advances in our understanding of specific diseases and they have made it possible to develop more accurate and sensitive diagnostic tests for the detection of the disease states.